M46.89 identifies an inflammatory spondylopathy of a specified type that does not fit a more precise M46 category and that affects two or more distinct spinal regions simultaneously.
Verified May 8, 2026 · 5 sources ↓
- Status
- Billable
- Chapter
- 13
- Related CPT
- 12
- Region
- Spine
Documentation tips
What should appear in the chart to support M46.89.
Source · Editorial brief grounded in 5 cited references ↓
- Identify the specific inflammatory spondylopathy by name (e.g., enteropathic spondylitis, undifferentiated spondyloarthropathy) — 'other specified' requires a named entity, not just symptoms.
- Document each spinal region involved (e.g., cervical and lumbar) to justify the 'multiple sites' qualifier; a single-region diagnosis maps to M46.80–M46.88 instead.
- Record MRI or CT findings that confirm multilevel inflammatory changes: bone marrow edema, Romanus lesions, syndesmophytes, or facet joint inflammation at more than one spinal level.
- Note any systemic inflammatory markers (CRP, ESR, HLA-B27 status) and their relationship to the spinal findings — this supports the inflammatory rather than degenerative classification.
- If a rheumatologist has established the diagnosis, cross-reference their documentation to align terminology and avoid a mismatch between the referring and treating provider's diagnostic language.
Related CPT procedures
Procedure codes commonly billed with M46.89. Linking the right diagnosis to the right procedure is what establishes medical necessity.
Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis
Common coding pitfalls
The recurring mistakes coders make with M46.89 and adjacent codes.
Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓
- Defaulting to M46.89 when only one spinal region is documented — single-site involvement requires M46.80 through M46.88 using the correct sixth-character site.
- Confusing 'other specified' with 'unspecified': M46.99 is the multiple-sites unspecified code; M46.89 requires the provider to have named a specific inflammatory entity.
- Using M46.89 for ankylosing spondylitis — that condition has its own category (M45.x) and should never be coded to M46.8x.
- Submitting M46.89 to support amniotic or placental-derived product injections without verifying payer policy — CMS Article A59764 lists it among diagnoses that do NOT support medical necessity for those procedures.
- Failing to code an underlying systemic disease (e.g., Crohn's disease, ulcerative colitis) as an additional diagnosis when enteropathic spondylitis is the specified entity — a 'Code Also' or etiology/manifestation convention may apply.
Clinical context
Source · Editorial summary grounded in 5 cited references ↓
Use M46.89 when the documented diagnosis is an inflammatory spondylopathy — not ankylosing spondylitis (M45), not psoriatic or reactive spondylitis, not discitis or vertebral osteomyelitis — and the condition spans multiple spinal sites. Common clinical scenarios include undifferentiated spondyloarthropathy with multilevel involvement, enteropathic spondylitis without a more specific index code, or early axial spondyloarthritis where imaging confirms multilevel inflammation but the provider has not yet established a classifiable subtype.
The 'other specified' qualifier is critical. It signals that the provider has named a condition distinct from the unspecified fallback (M46.99 for multiple sites). If the provider documents only 'inflammatory back pain' without identifying a specific entity, M46.99 is more appropriate. If involvement is limited to one spinal region, step down to the single-site sibling codes (M46.80 through M46.88) using the standard site-sixth-character convention.
M46.89 maps to MS-DRG 551 (Medical back problems with MCC) or 552 (Medical back problems without MCC) under MS-DRG v43.0. CMS explicitly lists M46.89 as a code supporting medical necessity for lumbar MRI (CMS LCD Article A57207), making accurate use of this code important for imaging authorization. CMS also lists it among codes that do NOT support medical necessity for amniotic/placental-derived product injections (Article A59764) — confirm payer policy before using this code to justify biologics or regenerative procedures.
Sibling codes
Other billable codes under M46.8 (laterality / anatomic variants).
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 5 cited references ↓
01What is the difference between M46.89 and M46.99?
02Can M46.89 be used for ankylosing spondylitis with multilevel involvement?
03Does M46.89 support lumbar MRI medical necessity under Medicare?
04Does M46.89 support amniotic or placental-derived product injections?
05Which MS-DRGs does M46.89 map to?
06How do I code enteropathic spondylitis with multilevel involvement?
07What sixth-character site codes are available if only one spinal region is affected?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CDC ICD-10-CM Tabular List 2026 (effective October 1, 2025)
- 02icd10data.comhttps://www.icd10data.com/ICD10CM/Codes/M00-M99/M45-M49/M46-/M46.89
- 03aapc.comhttps://www.aapc.com/codes/icd-10-codes/M46.89
- 04cms.govhttps://www.cms.gov/medicare-coverage-database/view/article.aspx?articleid=57207&ver=29
- 05cms.govhttps://www.cms.gov/medicare-coverage-database/view/article.aspx?articleid=59764&ver=7
Mira AI Scribe
Mira's AI scribe captures the specific inflammatory diagnosis name, the list of spinal regions affected, relevant imaging findings (MRI bone marrow edema, Romanus lesions, multilevel syndesmophytes), and any systemic inflammatory markers (HLA-B27, CRP, ESR) documented in the encounter. This prevents downcoding to unspecified M46.99 and ensures the 'multiple sites' qualifier is defensible on audit.
See how Mira captures M46.89 documentation